[HTML][HTML] Alzheimer's disease, obesity, and type 2 diabetes: focus on common neuroglial dysfunctions (critical review and new data on human brain and models)
A Toledano, A Rodríguez-Casado, MI Älvarez… - Brain Sciences, 2024 - mdpi.com
Background/Objectives. Obesity, type 2 diabetes (T2D), and Alzheimer's disease (AD) are
pathologies that affect millions of people worldwide. They have no effective therapy and are …
pathologies that affect millions of people worldwide. They have no effective therapy and are …
A review of the mechanisms of abnormal ceramide metabolism in type 2 diabetes mellitus, Alzheimer's disease, and their co-morbidities
Y Pan, J Li, P Lin, L Wan, Y Qu, L Cao… - Frontiers in …, 2024 - frontiersin.org
The global prevalence of type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) is
rapidly increasing, revealing a strong association between these two diseases. Currently …
rapidly increasing, revealing a strong association between these two diseases. Currently …
Interaction between the Neuroprotective and Hyperglycemia Mitigation Effects of Walnut-Derived Peptide LVRL via the Wnt3a/β-Catenin/GSK-3β Pathway in a Type 2 …
F Zhao, L Guo, T Huang, C Liu, D Wu… - Journal of Agricultural …, 2024 - ACS Publications
The term type 3 diabetes mellitus (T3DM) has been considered for Alzheimer's disease (AD)
due to the common molecular and cellular characteristics found between type 2 diabetes …
due to the common molecular and cellular characteristics found between type 2 diabetes …
Flavonoid-Rich Trianthema decandra Ameliorates Cognitive Dysfunction in the Hyperglycemic Rats
SS Momina, K Gandla - Biochemical Genetics, 2024 - Springer
The present study was aimed at the evaluation of neuroprotective ability of methanolic
extract of Trianthema decandra (METD) against hyperglycemia-related cognitive impairment …
extract of Trianthema decandra (METD) against hyperglycemia-related cognitive impairment …
Agonistes des récepteurs GLP-1 dans la maladie d'Alzheimer: Potentiel thérapeutique et mécanismes d'action
B Abdelhay, A Mustapha, E Lamiae, F Sofia - Médecine des Maladies …, 2024 - Elsevier
Résumé La maladie d'Alzheimer (MA) est un trouble neurodégénératif invalidant,
caractérisé par un déclin cognitif progressif et un dysfonctionnement neuronal. Les …
caractérisé par un déclin cognitif progressif et un dysfonctionnement neuronal. Les …
Alzheimer's Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A Toledano Gasca, A Rodríguez-Casado, MI Álvarez… - 2024 - digital.csic.es
Background/Objectives. Obesity, type 2 diabetes (T2D), and Alzheimer's disease (AD) are
pathologies that affect millions of people worldwide. They have no effective therapy and are …
pathologies that affect millions of people worldwide. They have no effective therapy and are …
[PDF][PDF] Synthesis, characterization and biological activity potential of some novel thiourea derivatives.
S TÜRK, D AKKAYA, B KIRILMAZ… - Journal of Research …, 2024 - researchgate.net
Within the scope of this study, a new series of thiourea derivatives were synthesized by
refluxing different anthranilic acid derivatives with various isothiocyanates in dry acetone …
refluxing different anthranilic acid derivatives with various isothiocyanates in dry acetone …
[PDF][PDF] Associação entre Diabetes Mellitus e doença de Alzheimer: aspetos nutricionais
LMF da Costa - 2024 - repositorio-aberto.up.pt
A Diabetes Mellitus e a doença de Alzheimer são condições crónicas complexas, com
prevalência crescente, altos custos associados e com fatores de risco comuns. A Diabetes …
prevalência crescente, altos custos associados e com fatores de risco comuns. A Diabetes …